CHEMED CORP CHE

Latest FY: 2025 Healthcare Medical Care Facilities
Market Price $512.97
Market Cap $6.80B
P/E Ratio 27.97
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑65.3% YoY
$2.53B
3-Yr CAGR: 28.2%
Net Income ↓-12.2% YoY
$265.24M
Net Margin: 10.5%
Free Cash Flow ↓-11.5% YoY
$325.48M
FCF Yield: 4.78%
EPS (Diluted) ↓-7.8% YoY
$18.34
Basic: $18.42
Return on Equity Efficiency
27.1%
ROA: 17.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CHE)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,576.9M $461.4M $108.7M $6.48 $0.98 0.61% $135.4M $95.6M
FY 2017 $1,666.7M +5.7% $516.2M $98.2M -9.7% $5.86 -9.6% $1.04 0.43% $162.5M $98.2M +2.7%
FY 2018 $1,197.6M -28.1% $-31.1M $205.5M +109.4% $12.23 +108.7% $1.11 0.39% $287.1M $234.3M +138.6%
FY 2019 $1,281.2M +7.0% $-39.9M $219.9M +7.0% $13.31 +8.8% $1.20 0.27% $301.2M $248.2M +6.0%
FY 2020 $1,334.7M +4.2% $-43.5M $319.5M +45.3% $19.48 +46.4% $1.29 0.24% $489.3M $430.5M +73.4%
FY 2021 $1,261.2M -5.5% $-108.2M $268.6M -15.9% $16.85 -13.5% $1.38 0.26% $308.6M $249.9M -41.9%
FY 2022 $1,201.6M -4.7% $-168.3M $249.6M -7.0% $16.53 -1.9% $1.46 0.29% $309.9M $252.6M +1.1%
FY 2023 $1,315.1M +9.4% $-150.5M $272.5M +9.2% $17.93 +8.5% $1.55 0.26% $330.3M $273.4M +8.3%
FY 2024 $1,531.0M +16.4% $-46.0M $302.0M +10.8% $19.89 +10.9% $1.78 0.34% $417.5M $368.0M +34.6%
FY 2025 $2,530.0M +65.3% $823.2M $265.2M -12.2% $18.34 -7.8% $2.19 0.51% $388.3M $325.5M -11.5%
$

Valuation

Market Price $512.97
Market Cap $6.80B
Enterprise Value $6.73B
P/E Ratio 27.97
P/B Ratio 6.92
FCF Yield 4.78%
Dividend Yield 0.43%
Shares Outstanding 13,219,400
%

Profitability & Margins

Gross Margin 32.54%
Operating Margin 13.37%
Net Margin 10.48%
Return on Equity (ROE) 27.08%
Return on Assets (ROA) 17.24%
Asset Turnover 1.64x
Revenue 3-Yr CAGR 28.17%
🛡️

Financial Health & Liquidity

Current Ratio 1.05
Cash Ratio 0.26
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $74.52M
Total Debt N/A
Book Value / Share $74.09
💧

Cash Flow Efficiency

Operating Cash Flow $388.27M
Capital Expenditures (CapEx) $62.80M
Free Cash Flow $325.48M
OCF / Revenue 15.35%
FCF / Revenue 12.86%
FCF 3-Yr CAGR 8.82%
🏷️

Per Share Metrics

EPS (Diluted) $18.34
EPS (Basic) $18.42
Dividends / Share $2.19
Book Value / Share $74.09
EPS YoY Growth -7.79%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.54B
Total Liabilities $558.78M
Stockholders' Equity $979.40M
Current Assets $302.62M
Current Liabilities $287.13M